基于电子的生活方式干预对非酒精性脂肪肝疾病的影响:系统性审查
Najmeh Seifi1, Hossein Bahari2, Sanaz Soltani1
1International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Digital health
|August 2, 2023
概括
在非酒精性脂肪性肝病 (NAFLD) 患者中,电子生活方式干预有效支持减肥,并改善非酒精性脂肪性肝病 (NAFLD) 患者的ALT和AST等肝酶. 这些数字健康工具为管理NAFLD提供了一个有希望的方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 数字健康数字健康
- 公共卫生 公共卫生
背景情况:
- 生活方式干预对于管理非酒精性脂肪性肝病 (NAFLD) 至关重要.
- 电子生活方式干预提供了一个可扩展的NAFLD管理方法.
- 需要综合证据来评估NAFLD电子健康干预措施的有效性.
研究的目的:
- 系统地审查有关NAFLD电子生活方式干预措施的证据.
- 评估电子健康对NAFLD患者体重,人体测量和肝酶的影响.
主要方法:
- 进行了临床试验的系统审查.
- 在Medline,Scopus和Web of Science进行了搜索,截至2023年2月.
- 包括七项临床试验,调查NAFLD的电子健康干预措施.
主要成果:
- 在七项研究中,有六项报告显著减肥.
- 在大多数研究中,电子干预显著降低了体重指数 (BMI) 和腰围 (WC).
- 大多数电子健康干预组观察到肝酶,氨酸转胺酶 (ALT) 和酸转胺酶 (AST) 的改善.
结论:
- 电子生活方式干预措施在减少NAFLD患者的体重,BMI和WC方面是有效的.
- 电子健康方法显示肝酶 (ALT和AST) 的显著改善.
- 数字健康干预措施是NAFLD管理的可行策略.
相关概念视频
Lifestyle Factors and Health
80
Lifestyle factors play a critical role in maintaining overall health and preventing chronic diseases. Key elements, such as regular physical activity, a nutritious diet, and abstinence from smoking, can significantly enhance physical, mental, and emotional well-being while reducing the risk of several life-threatening conditions.
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
80
Ultrasound II: Endoscopic Ultrasound and FibroScan
141
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
141
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Hypertension IV: Drug Therapy and Lifestyle Modifications
15
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
15
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
699
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
699


